SKVI · Skinvisible, Inc.
$0.43
At close · Sep 1
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raises substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.35M
Shares
5.40M
SKVI metrics
47 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.43
Market cap
$2.35M
Price action
19 metricsPrice change (1W)
+141.1%
Price change (30D)
+141.1%
Price change (3M)
+117.0%
Price change (6M)
—
Price change (YTD)
+88.2%
Price change (1Y)
+178.6%
Trailing year
Price change (5Y)
+210.0%
52-week high
$0.65
52-week low
$0.13
Change from 52-week high
-32.7%
Change from 52-week low
+247.2%
Annualized volatility
823.4%
Beta
—
RSI (14D)
64.5
Price vs SMA 50
+41.4%
Price vs SMA 200
+19.1%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
5.40M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
117.3×
reciprocal yield 0.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
611.1
reciprocal yield 0.2%
Earnings yield
-44.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
100.0%
Operating margin
-2,294.9%
Trailing 12 months
Net margin
-5,156.6%
Gross profit (TTM)
$20,000
Operating profit (TTM)
−$458,981
Net income (TTM)
−$1.03M
Trailing 12 months
Diluted EPS (TTM)
$-0.11
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+0.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$20,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
-58.5%
Revenue CAGR (5Y)
-33.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-836.2%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$438,742
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
-0.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$3,959
Latest balance sheet
Cash & equivalents
$3,959
Total assets
$123,334
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$3,838
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$458,742
Stock compensation (TTM)
$223,090
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged